Rapt Therapeutics, Inc. (RAPT)
35.10
+2.91
(+9.04%)
USD |
NASDAQ |
Jan 16, 16:00
34.98
-0.12
(-0.33%)
After-Hours: 20:00
Rapt Therapeutics Shareholders Equity (Annual): 189.90M for Dec. 31, 2024
Shareholders Equity (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Annual) Benchmarks
| Replimune Group, Inc. | 415.84M |
| Olema Pharmaceuticals, Inc. | 408.96M |
| NovaBay Pharmaceuticals, Inc. | -0.129M |
| Palatin Technologies, Inc. | -4.777M |
| Theriva Biologics, Inc. | 19.07M |